Calmodulin and alpha tocopherol as additional binding sites for doxorubicin

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Calcium-calmodulin (Ca2+-CaM) is a crucial signaling protein involved in numerous cellular processes.
• Doxorubicin (DXR) is a widely used chemotherapy agent with known interactions with biological molecules.
• Understanding DXR's interaction with Ca2+-CaM is vital for elucidating its mechanism of action and potential side effects.

Purpose of the Study:

• To investigate the effect of doxorubicin (DXR) on calcium-calmodulin (Ca2+-CaM) fluorescence.
• To determine the binding characteristics of DXR to the Ca2+-CaM complex.
• To explore the Ca2+ dependency of DXR's interaction with Ca2+-CaM.

Main Methods:

• Utilized hydrophobic fluorescent probes (9AC, ANSE, TNS) to monitor Ca2+-CaM fluorescence.
• Assessed the effect of varying concentrations of DXR on Ca2+-CaM fluorescence.
• Performed binding studies to quantify DXR-Ca2+-CaM complex formation (Kd, Bmax).
• Investigated the role of Ca2+ ions in DXR's interaction with Ca2+-CaM.

Main Results:

• Hydrophobic probes indicated increased Ca2+-CaM fluorescence.
• Doxorubicin (DXR) dose-dependently decreased Ca2+-CaM fluorescence.
• The effect of DXR was absolutely dependent on the presence of Ca2+ ions.
• DXR exhibited reversible binding to the Ca2+-CaM complex (Kd = 4.2 X 10(-5) M, Bmax = 1.8) and alpha-tocopherol.

Conclusions:

• DXR directly interacts with and inhibits the Ca2+-CaM complex in a Ca2+-dependent manner.
• This interaction suggests a mechanism by which DXR may affect Ca2+-CaM-mediated cellular functions.
• The findings support previous observations of DXR inhibiting Ca2+-CaM target enzymes and suggest broader implications for other CaM-dependent pathways.